Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-005-0069-7.

Title:
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma | Cancer Immunology, Immunotherapy
Description:
Purpose: We conducted a phase I trial of interleukin 2 (IL-2) in combination with chimeric 14.18 (ch14.18) and murine R24 antibodies to determine the maximal tolerated dose (MTD), immunological effects, and toxicity of this treatment combination. Experimental Design: Twenty-seven patients with either melanoma (23 patients) or sarcoma (4 patients) were enrolled to receive a combination therapy with ch14.18 and R24 antibodies together with continuous infusion of Roche IL-2 (1.5×106 U/m2/day, 26 patients) or Chiron IL-2 (4.5×106 U/m2/day, 1 patient) given 4 days/week for 3 weeks. The antibodies ch14.18 (2–7.5 mg/m2/day) and R24 (1–10 mg/m2/day) were scheduled to be administered for 5 days during the second week of IL-2 therapy. Results: When given in combination in this study, the MTD for ch14.18 was 5 mg/m2/day and the MTD for R24 was 5 mg/m2/day. Dose-limiting toxicities were severe allergic reactions to both ch14.18 and R24 as well as pain related to ch14.18. This ch14.18 MTD was lower than the 7.5 mg/m2/day MTD previously determined for ch14.18 given alone with the same dose and schedule of IL-2. Immunological effects included the induction of lymphokine-activated killer (LAK) activity and antibody-dependent cell-mediated cytoxicity (ADCC). Anti-idiotype response to ch14.18 was seen in six patients, including two melanoma patients who had a partial response to treatment. In addition to two partial responses, four patients had a stable disease and one patient remained without any evidence of disease. Conclusions: Immunotherapy with IL-2 in combination with ch14.18 and R24 antibodies augments LAK function and ADCC measured in vitro in all patients. While there exist theoretical advantages of combining these two antibodies, the MTD of ch14.18 and of R24 were lower than the MTD of each antibody in prior studies evaluating single antibody therapy with IL-2. As such, the combination of these two antibodies together with IL-2 therapy appeared to influence the MTD and toxicity of each of the administered antibodies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,328 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

google, scholar, cas, article, pubmed, cancer, patients, melanoma, sondel, antibody, interleukin, hank, phase, albertini, therapy, trial, monoclonal, gan, immunotherapy, antibodies, university, reisfeld, res, wisconsin, usa, treatment, mtd, tumor, clin, cell, combination, clinical, antigd, department, madison, chimeric, response, surfus, schiller, immunother, rosenberg, immunol, privacy, cookies, content, research, kendra, effects, mgmday, lymphocytes,

Topics {✒️}

antibody-dependent cell-mediated cytoxicity granulocyte-macrophage-colony stimulating factor month download article/chapter anti-gd2 antibody therapy li-yin lee chimeric anti-gd2 antibody antibody-dependent cytotoxicity adoptive-cell-transfer therapy targeted interleukin-2 therapy phase ib/ii trial antibody-cytokine fusion proteins lymphokine-activated killer nih grants m01-rr03186 article cancer immunology human neuroblastoma cells gd3 ganglioside full article pdf subcutaneous tumor mediated mouse monoclonal antibody renal cell cancer chimeric antidisialoganglioside antibody cell growth factor related subjects enhance tumor immunotherapy cultured autologous tumor privacy choices/manage cookies cell-mediated lysis nk cell assays shipe-spotloe jm r24 monoclonal antibody monoclonal antibody r24 il-2 therapy appeared potent antitumor response p30-ca14520 rights anti-idiotype vaccines anti-idiotype response anti-idiotypic response 5 mg/m2/day 1–10 mg/m2/day 18-il-2 fusion protein anti-gd3 phase ib trial maximal tolerated dose dose-limiting toxicities immunological effects included recombinant interleukin-2 preparations european economic area severe allergic reactions exist theoretical advantages invaded lymph node

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
         description: Purpose: We conducted a phase I trial of interleukin 2 (IL-2) in combination with chimeric 14.18 (ch14.18) and murine R24 antibodies to determine the maximal tolerated dose (MTD), immunological effects, and toxicity of this treatment combination. Experimental Design: Twenty-seven patients with either melanoma (23 patients) or sarcoma (4 patients) were enrolled to receive a combination therapy with ch14.18 and R24 antibodies together with continuous infusion of Roche IL-2 (1.5×106 U/m2/day, 26 patients) or Chiron IL-2 (4.5×106 U/m2/day, 1 patient) given 4 days/week for 3 weeks. The antibodies ch14.18 (2–7.5 mg/m2/day) and R24 (1–10 mg/m2/day) were scheduled to be administered for 5 days during the second week of IL-2 therapy. Results: When given in combination in this study, the MTD for ch14.18 was 5 mg/m2/day and the MTD for R24 was 5 mg/m2/day. Dose-limiting toxicities were severe allergic reactions to both ch14.18 and R24 as well as pain related to ch14.18. This ch14.18 MTD was lower than the 7.5 mg/m2/day MTD previously determined for ch14.18 given alone with the same dose and schedule of IL-2. Immunological effects included the induction of lymphokine-activated killer (LAK) activity and antibody-dependent cell-mediated cytoxicity (ADCC). Anti-idiotype response to ch14.18 was seen in six patients, including two melanoma patients who had a partial response to treatment. In addition to two partial responses, four patients had a stable disease and one patient remained without any evidence of disease. Conclusions: Immunotherapy with IL-2 in combination with ch14.18 and R24 antibodies augments LAK function and ADCC measured in vitro in all patients. While there exist theoretical advantages of combining these two antibodies, the MTD of ch14.18 and of R24 were lower than the MTD of each antibody in prior studies evaluating single antibody therapy with IL-2. As such, the combination of these two antibodies together with IL-2 therapy appeared to influence the MTD and toxicity of each of the administered antibodies.
         datePublished:2005-09-27T00:00:00Z
         dateModified:2005-09-27T00:00:00Z
         pageStart:761
         pageEnd:774
         sameAs:https://doi.org/10.1007/s00262-005-0069-7
         keywords:
            Melanoma
            Immunotherapy
            Ganglioside GD2
            Ganglioside GD3
            Antibody-dependent cell cytotoxicity
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig5_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:55
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Brian S. Choi
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Medicine, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul M. Sondel
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Human Oncology, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Wisconsin
                     address:
                        name:Department of Pediatrics, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Wisconsin
                     address:
                        name:Department of Genetics, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jacquelyn A. Hank
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Human Oncology, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heidi Schalch
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Medicine, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jacek Gan
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Human Oncology, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David M. King
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Medicine, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kari Kendra
               affiliation:
                     name:Ohio State University
                     address:
                        name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Mahvi
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Surgery, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Li-Yin Lee
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Biostatistics, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:KyungMann Kim
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Biostatistics, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark R. Albertini
               affiliation:
                     name:University of Wisconsin
                     address:
                        name:Department of Medicine, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Wisconsin
                     address:
                        name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
      description: Purpose: We conducted a phase I trial of interleukin 2 (IL-2) in combination with chimeric 14.18 (ch14.18) and murine R24 antibodies to determine the maximal tolerated dose (MTD), immunological effects, and toxicity of this treatment combination. Experimental Design: Twenty-seven patients with either melanoma (23 patients) or sarcoma (4 patients) were enrolled to receive a combination therapy with ch14.18 and R24 antibodies together with continuous infusion of Roche IL-2 (1.5×106 U/m2/day, 26 patients) or Chiron IL-2 (4.5×106 U/m2/day, 1 patient) given 4 days/week for 3 weeks. The antibodies ch14.18 (2–7.5 mg/m2/day) and R24 (1–10 mg/m2/day) were scheduled to be administered for 5 days during the second week of IL-2 therapy. Results: When given in combination in this study, the MTD for ch14.18 was 5 mg/m2/day and the MTD for R24 was 5 mg/m2/day. Dose-limiting toxicities were severe allergic reactions to both ch14.18 and R24 as well as pain related to ch14.18. This ch14.18 MTD was lower than the 7.5 mg/m2/day MTD previously determined for ch14.18 given alone with the same dose and schedule of IL-2. Immunological effects included the induction of lymphokine-activated killer (LAK) activity and antibody-dependent cell-mediated cytoxicity (ADCC). Anti-idiotype response to ch14.18 was seen in six patients, including two melanoma patients who had a partial response to treatment. In addition to two partial responses, four patients had a stable disease and one patient remained without any evidence of disease. Conclusions: Immunotherapy with IL-2 in combination with ch14.18 and R24 antibodies augments LAK function and ADCC measured in vitro in all patients. While there exist theoretical advantages of combining these two antibodies, the MTD of ch14.18 and of R24 were lower than the MTD of each antibody in prior studies evaluating single antibody therapy with IL-2. As such, the combination of these two antibodies together with IL-2 therapy appeared to influence the MTD and toxicity of each of the administered antibodies.
      datePublished:2005-09-27T00:00:00Z
      dateModified:2005-09-27T00:00:00Z
      pageStart:761
      pageEnd:774
      sameAs:https://doi.org/10.1007/s00262-005-0069-7
      keywords:
         Melanoma
         Immunotherapy
         Ganglioside GD2
         Ganglioside GD3
         Antibody-dependent cell cytotoxicity
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig5_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:55
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Brian S. Choi
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Medicine, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul M. Sondel
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Human Oncology, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Wisconsin
                  address:
                     name:Department of Pediatrics, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Wisconsin
                  address:
                     name:Department of Genetics, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jacquelyn A. Hank
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Human Oncology, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heidi Schalch
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Medicine, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jacek Gan
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Human Oncology, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David M. King
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Medicine, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kari Kendra
            affiliation:
                  name:Ohio State University
                  address:
                     name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Mahvi
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Surgery, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Li-Yin Lee
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Biostatistics, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:KyungMann Kim
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Biostatistics, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark R. Albertini
            affiliation:
                  name:University of Wisconsin
                  address:
                     name:Department of Medicine, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Wisconsin
                  address:
                     name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:55
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Wisconsin
      address:
         name:Department of Medicine, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Human Oncology, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Pediatrics, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Genetics, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Human Oncology, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Medicine, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Human Oncology, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Medicine, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:Ohio State University
      address:
         name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Surgery, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Biostatistics, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Biostatistics, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:Department of Medicine, University of Wisconsin, Madison, USA
         type:PostalAddress
      name:University of Wisconsin
      address:
         name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Brian S. Choi
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Medicine, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Paul M. Sondel
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Human Oncology, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
            name:University of Wisconsin
            address:
               name:Department of Pediatrics, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
            name:University of Wisconsin
            address:
               name:Department of Genetics, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Jacquelyn A. Hank
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Human Oncology, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Heidi Schalch
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Medicine, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Jacek Gan
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Human Oncology, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:David M. King
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Medicine, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Kari Kendra
      affiliation:
            name:Ohio State University
            address:
               name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
      name:David Mahvi
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Surgery, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Li-Yin Lee
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Biostatistics, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:KyungMann Kim
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Biostatistics, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      name:Mark R. Albertini
      affiliation:
            name:University of Wisconsin
            address:
               name:Department of Medicine, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
            name:University of Wisconsin
            address:
               name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medicine, University of Wisconsin, Madison, USA
      name:Department of Human Oncology, University of Wisconsin, Madison, USA
      name:Department of Pediatrics, University of Wisconsin, Madison, USA
      name:Department of Genetics, University of Wisconsin, Madison, USA
      name:Department of Human Oncology, University of Wisconsin, Madison, USA
      name:Department of Medicine, University of Wisconsin, Madison, USA
      name:Department of Human Oncology, University of Wisconsin, Madison, USA
      name:Department of Medicine, University of Wisconsin, Madison, USA
      name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
      name:Department of Surgery, University of Wisconsin, Madison, USA
      name:Department of Biostatistics, University of Wisconsin, Madison, USA
      name:Department of Biostatistics, University of Wisconsin, Madison, USA
      name:Department of Medicine, University of Wisconsin, Madison, USA
      name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(131)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.44s.